Chemomab Therapeutics Announces Third Quarter 2024 …

2 days ago · Cash Position and Liquidity: Cash and short-term bank deposits were $19.5 million as of September 30, 2024, as compared to $12.8 million as of June 30, 2024 and $19.9 million …

CouponFollow Extension

$19
OFF

Chemomab Therapeutics Announces Third Quarter 2024 …

1 week from now

2 days ago · Cash Position and Liquidity: Cash and short-term bank deposits were $19.5 million as of September 30, 2024, as compared to $12.8 million as of June 30, 2024 and $19.9 million …

chemomab.com

$19
OFF

Chemomab Therapeutics Sees Cash Runway Through Beginning Of …

1 week from now

2 days ago · Cash and short-term bank deposits were $19.5 million as of September 30, 2024, as compared to $12.8 million as of June 30, 2024 and $19.9 million as of December 31, 2023. …

businessinsider.com

$19
OFF

Chemomab Therapeutics Announces Third Quarter 2024 Financial …

1 week from now

2 days ago · Cash Position and Liquidity: Cash and short-term bank deposits were $19.5 million as of September 30, 2024, as compared to $12.8 million as of June 30, 2024 and $19.9 million …

morningstar.com

$12
OFF

Chemomab Therapeutics Announces Second Quarter 2024 …

1 week from now

Aug 21, 2024 · Cash Position: Cash, cash equivalents and short-term bank deposits were $12.8 million as of June 30, 2024, compared to $19.9 million as of December 31, 2023. On July 30, …

chemomab.com

$10
OFF

Chemomab Therapeutics Announces Closing Of $10 Million

1 week from now

Jul 30, 2024 · Chemomab closed a $10 million PIPE financing that included new and existing top tier investors and extends the cash runway through the beginning of 2026... July 30, 2024 …

globenewswire.com

$10
OFF

Chemomab Therapeutics Ltd. (CMMB) - Stock Analysis

1 week from now

Nov 8, 2024 · Get a real-time Chemomab Therapeutics Ltd. (CMMB) stock price quote with breaking news, financials, statistics, charts and more. ... Chemomab closed a $10 million PIPE …

stockanalysis.com

$10
OFF

Chemomab Therapeutics Announces $10 Million Private Placement

1 week from now

Jul 25, 2024 · Chemomab expects that the net proceeds from the PIPE will extend its cash runway to fund its operations through the beginning of 2026, an extension of approximately …

nasdaq.com

$10
OFF

Chemomab Therapeutics Secures $10 Million Private Placement

1 week from now

July 30, 2024. Chemomab Therapeutics Announces Closing of $10 Million Private Placement. Recently, Chemomab Therapeutics Ltd announced the successful closing of a $10 million …

csimarket.com

$10
OFF

Chemomab Therapeutics Announces $10 Million Private Placement

1 week from now

Jul 25, 2024 · Chemomab expects that the net proceeds from the PIPE will extend its cash runway to fund its operations through the beginning of 2026, an extension of approximately one year from current projections, which should fund the Company for approximately one year after the completion of two major milestones expected in early 2025.

chemomab.com

$10
OFF

Chemomab Trumpets Liver Disease Win, But Investors Retreat

1 week from now

Jul 25, 2024 · Chemomab, which was set to run out of money in the first quarter of 2025, disclosed a $10 million private placement alongside the data. The investment will extend the …

fiercebiotech.com

$12
OFF

Chemomab Therapeutics Announces Second Quarter 2024

1 week from now

Aug 21, 2024 · Cash Position: Cash, cash equivalents and short-term bank deposits were $12.8 million as of June 30, 2024, compared to $19.9 million as of December 31, 2023. On July 30, …

globenewswire.com

FAQs about Chemomab Therapeutics Announces Third Quarter 2024 … Coupon?

How much money did chemomab make in 2024?

Cash and short-term bank deposits were $19.5 million as of September 30, 2024, as compared to $12.8 million as of June 30, 2024 and $19.9 million as of December 31, 2023. During the third quarter of 2024 Chemomab completed a private placement that resulted in gross proceeds to the company of approximately $10 million. ...

Will chemomab extend its cash runway until 2026?

Chemomab announced a $10 million PIPE that enables the company to extend its cash runway until early 2026, well past 2 upcoming milestones in early 2025. Chemomab reported positive topline results from Ph 2 trial assessing CM-101 in PSC. Achieved safety endpoint and improved wide range of secondary endpoints ...

Will chemomab be able to fund its operations through 2026?

: Chemomab believes its existing liquidity resources as of June 30, 2024, together with the additional funds of approximately $10 million raised in July 2024, will enable the Company to fund its operations through the beginning of 2026. ...

What happened to chemomab?

On July 30, 2024, Chemomab announced the closing of a private placement that resulted in gross proceeds of approximately $10 million. Existing investors such as OrbiMed and new investors including HBM Partners and Sphera Biotech Master Fund participated in the financing, which extends the company’s cash runway through early 2026. ...

Who financed chemomab?

Existing investors such as OrbiMed and new investors including HBM Partners and Sphera Biotech Master Fund participated in the financing, which extends the company’s cash runway through early 2026. On July 25, 2024, Chemomab reported topline results from the CM-101 Phase 2 SPRING trial in patients with PSC. ...

Who is chemomab Therapeutics Ltd?

Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel. CMMB | A complete CMMB overview by MarketWatch. ...